Health Highlights: Oct. 1, 2021
Merck to seek emergency approval for its new COVID antiviral pill: In a trial of the drug molnupiravir, the risk of hospitalization and death was halved when given to high-risk patients within five days of infection. Read more
Has the pandemic made the opioid epidemic worse? In interviews with HealthDay Now, experts say that overdoses soared, but the rise of telehealth also helped many get vital treatments. Read more
A silver lining to the pandemic: less vaping among teens. New statistics show a 40% drop in use, as teens had to stay home more during lockdowns and closures. Read more
New data shows police killings underreported: And Black Americans were 3.5 times more likely to die from police violence than white Americans, the study found. Read more
Related Posts
For Women Delaying Childbirth, Freezing Eggs May Be Best Option: Study
WEDNESDAY, June 1, 2022 (HealthDay News) -- Not every woman is ready to become a...
Major Drug Companies Agree to Price Negotiations With U.S. Government
TUESDAY, Oct. 3, 2023 (HealthDay News) -- Pharmaceutical companies that make the...
La lactancia materna podría potenciar la capacidad mental de un niño, muestra un estudio
JUEVES, 26 de mayo de 2022 (HealthDay News) -- Hace mucho que se piensa que la...
MRI May Be Preferred to CT With CT Angiography Alone for Dizziness in ED
THURSDAY, July 13, 2023 (HealthDay News) -- For patients presenting to the...